Bailong Chuangyuan plans a RMB 1.123 billion expansion to boost functional sugar production, but the first batch of companies racing to secure 'sugar energy' have yet to attract customers.

Allulose is riding the tailwind, with capacity expansion outpacing demand.

lanjinger.comJun 11 15:17

Bailong Chuangyuan (605016): A High-Growth Leader in Functional Food Ingredients

Bailong Chuangyuan: A leading domestic producer of functional food ingredients. Founded in 2005, the company currently offers product lines primarily comprising prebiotics, dietary fibers, healthy sweeteners, and other starch sugars (sugar alcohols), with the capacity to produce more than 200 varieties of

Everbright SecuritiesMay 30 00:00

Bailong Chuangyuan (605016.SH) 2025 Annual Dividend Distribution: RMB 0.165 per share

Gelonghui, May 26 — Bailong Chuangyuan (SHA: 605016) announced its 2025 annual profit distribution implementation notice. The dividend distribution is based on the company's total share capital of 420,012,320 shares prior to the implementation of the plan, with a cash dividend of RMB 0.165 per share (inclusive of tax), amounting to a total cash dividend of RMB 69,302,032.80. The record date for this equity distribution is June 1, 2026, and the ex-dividend date is June 2, 2026.

Gelonghui FinanceMay 26 17:41

Bailong Chuangyuan (605016): Profitability Continues to Improve; Growth from New Markets and Additional Capacity Expected

Event Description: On April 8 and April 30, the company released its 2025 annual report and its Q1 2026 report, respectively. For the full year of 2025, the company achieved revenue of RMB 1.379 billion, an increase of 19.75% year-over-year; attributable to

Huaan SecuritiesMay 25 16:56

Bailong Chuangyuan (605016): Quarterly performance hits a new high as product sales continue to grow.

The company released its Q1 2026 earnings report. In Q1 2026, the company achieved total operating revenue of 390 million yuan, representing a year-on-year increase of 25.3%; net profit attributable to shareholders reached 120 million yuan, up 48.1% year-on-year; non-recurring net profit amounted to 120 million yuan.

Changjiang SecuritiesMay 19 13:32

Shanghai Bourse Accepts Bailong Chuangyuan Bio-Tech's Convertible Bond Issuance Application

MT NewswiresMay 6 16:02